Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CML
CML
Novartis’ Scemblix meets primary endpoints in Phase III leukemia trial
Clinical Trials Arena
Mon, 01/8/24 - 11:41 am
Novartis
clinical trials
Scemblix
asciminib
CML
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Thu, 10/20/22 - 12:21 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Thu, 10/20/22 - 12:27 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data
Fierce Pharma
Fri, 05/27/22 - 10:21 am
ASCO 2022
Novartis
Gleevec
Scemblix
CML
chronic myeloid leukemia
FDA Approves Scemblix for Pretreated CML in the Chronic Phase
Cure Today
Sat, 10/30/21 - 10:46 pm
Novartis
Scemblix
FDA
CML
ASH20: Out to shake up CML once again, Novartis lays out head-to-head between third-gen Gleevec scion and Pfizer rival
Endpoints
Tue, 12/8/20 - 11:08 pm
ASH2020
Novartis
CML
asciminib
Pfizer
ASH: Takeda pads case for new leukemia use with 5-year survival data
Fierce Pharma
Tue, 12/8/20 - 12:11 am
Takeda
ASH2020
CML
Iclusig
Xspray Pharma reports positive clinical data for HyNap-Dasa product candidate
Pharmaceutical Business Review
Mon, 09/10/18 - 09:30 am
Xspray Pharma
clinical trials
HyNap-Dasa
CML
chronic myeloid leukemia
Pfizer's blood cancer drug Bosulif effective in untreated patients
Yahoo/Reuters
Mon, 12/5/16 - 10:06 am
Pfizer
Bosulif
chronic myeloid leukemia
CML
2 Pharmas That Should Move After 55th ASH Meeting
Seeking Alpha
Wed, 11/20/13 - 11:01 am
ASH
Iclusig
Ariad Pharmaceuticals
SL-401
CML
Stemline
Ariad Pharmaceuticals Plummets 70% as Drug Trial Held
Barron's
Wed, 10/9/13 - 04:00 pm
Ariad Pharmaceuticals
Iclusig
CML
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
Seeking Alpha
Wed, 05/22/13 - 04:42 pm
Gleevec
Ariad Pharmaceuticals
Iclusig
CML
Novartis
chronic myeloid leukemia
2 Biotech Companies With Strong Product Launches To Monitor
Seeking Alpha
Tue, 05/14/13 - 05:29 pm
Uceris
Santarus
ulcerative colitis
Iclusig
Ariad Pharmaceuticals
CML
chronic myeloid leukemia
Does Ariad's Leukemia Drug Have Hidden Potential?
Motley Fool
Wed, 05/8/13 - 09:11 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
CML
Doctors blast ethics of $100,000 cancer drugs
CNN Money
Fri, 04/26/13 - 10:34 am
physicians
drug pricing
CML
Gleevec
Novartis
Pfizer's Oncology Division Gets A Boost With European Approval For Bosulif
Seeking Alpha
Fri, 04/5/13 - 10:26 am
Pfizer
oncology
Bosulif
CML
Ariad CEO Strikes Back, Insists Leukemia Drug Is Fine
TheStreet.com
Thu, 04/4/13 - 01:44 pm
CML
Ariad Pharmaceuticals
Iclusig
The Survey Says: Ariad's Leukemia Drug Is Toxic
TheStreet.com
Wed, 04/3/13 - 02:36 pm
Ariad Pharmaceuticals
CML
Iclusig
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Seeking Alpha
Mon, 10/1/12 - 11:27 am
Ponatinib
CML
Ariad Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Novartis
Medco, MolecularMD team on CML test
Thu, 06/2/11 - 02:55 pm
Medco
CML